Methods and compositions for delivery of growth factor to fibrous connective tissue
View Patent ↗The presently disclosed subject matter relates to a peptide composition for non-covalently localizing fibrous connective tissue-inducing growth factor to a surface of an implant, the composition comprising a peptide having binding affinity for a surface material of an implant coupled to a peptide having binding affinity for a fibrous connective tissue-inducing growth factor. Methods are provided for delivering fibrous connective tissue-inducing growth factor GDF-7 in an amount effective to promote fibrous connective tissue repair and fibrous connective tissue formation. Also provided are methods of applying the peptide composition to an implant by contacting the composition with a surface of the implant; and kits comprising the compositions.
1. A method for stimulating production of fibrous connective tissue in a subject, the method comprising:
placing an implant comprising a peptide (i) having a sequence at least 95% identical to the sequence set forth in SEQ ID NO: 1 or SEQ ID NO: 3 or (ii) having a sequence with no more than 3 conservative amino acid substitutions in SEQ ID NO: 1 or SEQ ID NO: 3 at a target site in the subject, wherein the peptide has binding affinity for fibrous connective tissue-inducing growth factor (GDF), and localization of the GDF by binding to the peptide at the target site stimulates production of fibrous connective tissue.
2. The method of claim 1 , wherein the fibrous connective tissue-inducing growth factor is GDF-7.
3. A GDF binding domain comprising a peptide having a sequence at least 95% identical to SEQ ID NO: 1 or SEQ ID NO: 3, or having a sequence with no more than 3 conservative amino acid substitutions in SEQ ID NO: 1 or SEQ ID NO: 3, wherein the binding domain has binding affinity for GDF-7.
4. The GDF binding domain of claim 1 , wherein the binding domain is no more than 30 amino acids in length.
5. The GDF binding domain of claim 1 , wherein the binding domain is no more than 40 amino acids in length.
6. The GDF binding domain of claim 3 , wherein the peptide has at least 97% sequence identity to SEQ ID NO: 1 or SEQ ID NO: 3.
7. An implant comprising a peptide having a sequence at least 95% identical to SEQ ID NO: 1 or SEQ ID NO: 3, or having a sequence with no more than 3 conservative amino acid substitutions in SEQ ID NO: 1 or SEQ ID NO: 3, wherein the peptide has binding affinity for GDF-7.
8. The implant of claim 7 , wherein the peptide has a sequence at least 97% identical to SEQ ID NO: 1 or SEQ ID NO: 3.
9. The implant of claim 7 , wherein the peptide is no more than 30 amino acids in length.
10. The implant of claim 7 , wherein the peptide is no more than 40 amino acids in length.
11. The method of claim 1 , wherein the peptide has a sequence at least 97% identical to SEQ ID NO: 1 or SEQ ID NO: 3.
12. The method of claim 1 , wherein the peptide is no more than 30 amino acids in length.
13. The method of claim 1 , wherein the peptide is no more than 40 amino acids in length.